AbbVie (ABBV)
(Delayed Data from NYSE)
$159.62 USD
-7.67 (-4.58%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $160.06 +0.44 (0.28%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/25/24 |
---|---|
Current Quarter | 2.79 |
EPS Last Quarter | 2.31 |
Last EPS Surprise | 2.21% |
ABR | 1.89 |
Earnings ESP
|
-1.34% |
---|---|
Current Year | 11.10 |
Next Year | 12.13 |
EPS (TTM) | 10.96 |
P/E (F1) | 14.38 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 13.51B | 14.13B | 54.63B | 58.45B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 13.72B | 14.34B | 55.76B | 59.76B |
Low Estimate | 12.99B | 13.88B | 54.24B | 56.93B |
Year ago Sales | 13.87B | 13.93B | 54.32B | 54.63B |
Year over Year Growth Est. | -2.54% | 1.45% | 0.58% | 6.99% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.79 | 2.91 | 11.10 | 12.13 |
# of Estimates | 9 | 9 | 8 | 11 |
Most Recent Consensus | 2.21 | 2.84 | 11.06 | 11.86 |
High Estimate | 2.92 | 2.97 | 11.35 | 12.62 |
Low Estimate | 2.62 | 2.81 | 10.99 | 11.71 |
Year ago EPS | 2.91 | 2.95 | 11.11 | 11.10 |
Year over Year Growth Est. | -4.12% | -1.36% | -0.09% | 9.27% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 1 | 2 | 1 | 1 |
Up Last 60 Days | 1 | 2 | 1 | 2 |
Down Last 7 Days | 1 | 0 | 2 | 1 |
Down Last 30 Days | 3 | 0 | 6 | 4 |
Down Last 60 Days | 3 | 0 | 6 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.79 | 2.91 | 11.10 | 12.13 |
7 Days Ago | 2.79 | 2.91 | 11.16 | 12.14 |
30 Days Ago | 2.79 | 2.90 | 11.17 | 12.20 |
60 Days Ago | 2.79 | 2.90 | 11.17 | 12.12 |
90 Days Ago | 2.85 | 2.91 | 11.30 | 12.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.75 | 2.95 | 11.11 | 12.26 |
Zacks Consensus Estimate | 2.79 | 2.91 | 11.10 | 12.13 |
Earnings ESP | -1.34% | 1.27% | 0.06% | 1.05% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.31 | 2.79 | 2.95 | 2.91 | NA |
Estimate | 2.26 | 2.76 | 2.86 | 2.79 | NA |
Difference | 0.05 | 0.03 | 0.09 | 0.12 | 0.07 |
Surprise | 2.21% | 1.09% | 3.15% | 4.30% | 2.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more